Given the data and tweets, could you project whether the closing price of $bmy will grow or shrink at 2017-04-25? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-04-10,0.0,0.7,-0.3,-0.1,-0.1,0.1,1.4,2.3,3.2,3.9,4.3
2017-04-11,0.6,0.9,-0.1,-0.7,-0.7,0.5,1.6,2.7,3.6,4.4,4.8
2017-04-12,-0.3,0.3,-0.5,0.0,0.0,0.4,1.1,2.3,3.2,4.1,4.5
2017-04-13,0.4,0.7,-0.1,-0.3,-0.3,0.5,1.0,2.3,3.1,4.1,4.6
2017-04-17,-0.4,0.5,-0.8,0.2,0.2,0.1,0.6,1.8,2.6,3.4,4.1
2017-04-18,-0.5,0.4,-0.6,-0.0,-0.0,0.0,0.4,1.5,2.3,3.2,3.9
2017-04-19,-0.4,0.9,-0.6,0.5,0.5,-0.4,-0.2,0.6,1.6,2.5,3.2
2017-04-20,-0.1,0.2,-0.5,0.5,0.5,-0.7,-0.6,-0.1,0.9,1.7,2.6
2017-04-21,-0.1,0.4,-0.6,0.1,0.1,-0.5,-0.6,-0.3,0.7,1.4,2.2
2017-04-24,0.6,0.8,-0.1,0.1,0.1,-0.4,-0.7,-0.5,0.4,1.1,1.8

2017-04-10: rt AT_USER insider trading activity bristol-myers squibb co (nyse:bmy) ¨c director sold 34,000 shares of stock |insider selling: bristol-myers squibb co $bmy director sells 34,000 shares of stock |ins
2017-04-11: rt AT_USER AT_USER AT_USER here it is dr pat topline data this summer AT_USER $nwbo $nk $cncr $bmy cure is¡­|rt AT_USER AT_USER AT_USER here it is dr pat topline data this summer AT_USER $nwbo $nk $cn
2017-04-12: bms $bmy and #apexigen to evaluate #opdivo (#nivolumab) in combination with #apx005m in advanced #solidtumors |bms and pfizer file 16 eliquis patent lawsuits to waylay generic makers  $bmy $pfe|$lulu 
2017-04-13: #bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen and roc... read more:  $bmy|#bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen an
2017-04-14: is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #
2017-04-15: rt AT_USER amazing how darzalex $jnj has pulled ahead of empliciti $bmy. here's sellside consensus change over 2 years ($m), via AT_USER|rt AT_USER $bmy makes survival in melanoma combo trial. $mrk, #
2017-04-16: AT_USER could you run a valuation on $nwbo? phase 3 readouts soon and looks incredibly undervalued. possib¡­ | learn 2 trade stocks with jason bond and quit your job [free trial]  $mrk $bmy $xbi $fb $
2017-04-17: $bmy inks news partnership focused on nash |rt AT_USER you get a new r&amp;d head, and you get a new r&amp;d head... $bmy $mack $juno $srpt |bristol-myers squibb $bmy given news sentiment score of 0.1
2017-04-18: healthcare dogs see medical care tops by yield but big pharma tops by gains for april  $abbv $azn $bmy $exetf $gsk|healthcare dogs see medical care tops by yield but big pharma tops by gains for april
2017-04-19: bristol-myers squibb co $bmy insider sells $282,450.00 in stock |#breaking bristol-myers 'holding up better,' but dow's merck still gouging share $bmy $mrk  |rt AT_USER bristol-myers preps 2nd #checkp
2017-04-20: AT_USER AT_USER $bmy and $mrk waiting on topline data in coming weeks from $nwbo  like $cpxx traders wil¡­ |bristol-myers squibb co $bmy shares bought by zurich insurance group ltd fi |bristol-myers s
2017-04-21: rt AT_USER $gild ceo doesn't m/a before earnings, probably will be looking for a new job. $incy $tsro $bmy|is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow 
2017-04-22: rt AT_USER new report halves the number of people infected with hepatitis c worldwide | science $gild $bmy $mrk $abbv $rgls |rt AT_USER news from #ilc2017: $bmy¡¯s nash drug reduces liver fat in phase
2017-04-23: AT_USER how about a deal for $bmy or $hain....|AT_USER sounds promising but not sure it'll move the needle on this one. i'm very nervous about the earnings. $bmy|rt AT_USER no more free research/conte
2017-04-24: $bti.v makes a great hire at the ceo position. expect more partnerships to follow. $bmy $mrk $nvs $biib |$bmy's drug cuts liver fat in nash  #easl2017 #ilc2017|rt AT_USER nash - the next untapped phar
Answer:
Given the data and tweets, could you project whether the closing price of $bmy will grow or shrink at 2017-04-25? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-04-10,0.0,0.7,-0.3,-0.1,-0.1,0.1,1.4,2.3,3.2,3.9,4.3
2017-04-11,0.6,0.9,-0.1,-0.7,-0.7,0.5,1.6,2.7,3.6,4.4,4.8
2017-04-12,-0.3,0.3,-0.5,0.0,0.0,0.4,1.1,2.3,3.2,4.1,4.5
2017-04-13,0.4,0.7,-0.1,-0.3,-0.3,0.5,1.0,2.3,3.1,4.1,4.6
2017-04-17,-0.4,0.5,-0.8,0.2,0.2,0.1,0.6,1.8,2.6,3.4,4.1
2017-04-18,-0.5,0.4,-0.6,-0.0,-0.0,0.0,0.4,1.5,2.3,3.2,3.9
2017-04-19,-0.4,0.9,-0.6,0.5,0.5,-0.4,-0.2,0.6,1.6,2.5,3.2
2017-04-20,-0.1,0.2,-0.5,0.5,0.5,-0.7,-0.6,-0.1,0.9,1.7,2.6
2017-04-21,-0.1,0.4,-0.6,0.1,0.1,-0.5,-0.6,-0.3,0.7,1.4,2.2
2017-04-24,0.6,0.8,-0.1,0.1,0.1,-0.4,-0.7,-0.5,0.4,1.1,1.8

2017-04-10: rt AT_USER insider trading activity bristol-myers squibb co (nyse:bmy) ¨c director sold 34,000 shares of stock |insider selling: bristol-myers squibb co $bmy director sells 34,000 shares of stock |ins
2017-04-11: rt AT_USER AT_USER AT_USER here it is dr pat topline data this summer AT_USER $nwbo $nk $cncr $bmy cure is¡­|rt AT_USER AT_USER AT_USER here it is dr pat topline data this summer AT_USER $nwbo $nk $cn
2017-04-12: bms $bmy and #apexigen to evaluate #opdivo (#nivolumab) in combination with #apx005m in advanced #solidtumors |bms and pfizer file 16 eliquis patent lawsuits to waylay generic makers  $bmy $pfe|$lulu 
2017-04-13: #bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen and roc... read more:  $bmy|#bristolmyerssquibb bristol-myers squibb enters into separate agreements with biogen an
2017-04-14: is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #
2017-04-15: rt AT_USER amazing how darzalex $jnj has pulled ahead of empliciti $bmy. here's sellside consensus change over 2 years ($m), via AT_USER|rt AT_USER $bmy makes survival in melanoma combo trial. $mrk, #
2017-04-16: AT_USER could you run a valuation on $nwbo? phase 3 readouts soon and looks incredibly undervalued. possib¡­ | learn 2 trade stocks with jason bond and quit your job [free trial]  $mrk $bmy $xbi $fb $
2017-04-17: $bmy inks news partnership focused on nash |rt AT_USER you get a new r&amp;d head, and you get a new r&amp;d head... $bmy $mack $juno $srpt |bristol-myers squibb $bmy given news sentiment score of 0.1
2017-04-18: healthcare dogs see medical care tops by yield but big pharma tops by gains for april  $abbv $azn $bmy $exetf $gsk|healthcare dogs see medical care tops by yield but big pharma tops by gains for april
2017-04-19: bristol-myers squibb co $bmy insider sells $282,450.00 in stock |#breaking bristol-myers 'holding up better,' but dow's merck still gouging share $bmy $mrk  |rt AT_USER bristol-myers preps 2nd #checkp
2017-04-20: AT_USER AT_USER $bmy and $mrk waiting on topline data in coming weeks from $nwbo  like $cpxx traders wil¡­ |bristol-myers squibb co $bmy shares bought by zurich insurance group ltd fi |bristol-myers s
2017-04-21: rt AT_USER $gild ceo doesn't m/a before earnings, probably will be looking for a new job. $incy $tsro $bmy|is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow 
2017-04-22: rt AT_USER new report halves the number of people infected with hepatitis c worldwide | science $gild $bmy $mrk $abbv $rgls |rt AT_USER news from #ilc2017: $bmy¡¯s nash drug reduces liver fat in phase
2017-04-23: AT_USER how about a deal for $bmy or $hain....|AT_USER sounds promising but not sure it'll move the needle on this one. i'm very nervous about the earnings. $bmy|rt AT_USER no more free research/conte
2017-04-24: $bti.v makes a great hire at the ceo position. expect more partnerships to follow. $bmy $mrk $nvs $biib |$bmy's drug cuts liver fat in nash  #easl2017 #ilc2017|rt AT_USER nash - the next untapped phar
Answer:+Rise